PK and PD Study of LUM-201 in Children With Growth Hormone Deficiency
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The goals of this single site trial are to study the pharmacokinetics (PK) and
pharmacodynamics of LUM-201 and effects of LUM-201 administration on growth hormone release
over time in children with pediatric growth hormone deficiency (PGHD).